JP2020534118A - ストレス低減及び睡眠促進システム - Google Patents
ストレス低減及び睡眠促進システム Download PDFInfo
- Publication number
- JP2020534118A JP2020534118A JP2020536912A JP2020536912A JP2020534118A JP 2020534118 A JP2020534118 A JP 2020534118A JP 2020536912 A JP2020536912 A JP 2020536912A JP 2020536912 A JP2020536912 A JP 2020536912A JP 2020534118 A JP2020534118 A JP 2020534118A
- Authority
- JP
- Japan
- Prior art keywords
- sleep
- sensor
- layer
- user
- stress reduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 501
- 230000009467 reduction Effects 0.000 title claims abstract description 96
- 239000012530 fluid Substances 0.000 claims description 170
- 239000000463 material Substances 0.000 claims description 109
- 230000007613 environmental effect Effects 0.000 claims description 45
- 230000005672 electromagnetic field Effects 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 230000033001 locomotion Effects 0.000 claims description 32
- 230000008667 sleep stage Effects 0.000 claims description 22
- 230000036760 body temperature Effects 0.000 claims description 21
- 238000004891 communication Methods 0.000 claims description 21
- 230000006854 communication Effects 0.000 claims description 21
- 230000007175 bidirectional communication Effects 0.000 claims description 15
- 230000036772 blood pressure Effects 0.000 claims description 15
- 210000004556 brain Anatomy 0.000 claims description 11
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 10
- 230000004424 eye movement Effects 0.000 claims description 7
- 230000006698 induction Effects 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 210000000577 adipose tissue Anatomy 0.000 claims description 6
- 230000002093 peripheral effect Effects 0.000 claims description 4
- 230000007383 nerve stimulation Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 70
- 238000010586 diagram Methods 0.000 abstract description 13
- 230000035882 stress Effects 0.000 description 138
- 238000011282 treatment Methods 0.000 description 44
- 230000036541 health Effects 0.000 description 40
- 230000008859 change Effects 0.000 description 29
- 230000000694 effects Effects 0.000 description 27
- 125000006850 spacer group Chemical group 0.000 description 27
- 238000012545 processing Methods 0.000 description 24
- 230000003860 sleep quality Effects 0.000 description 24
- 238000005286 illumination Methods 0.000 description 23
- 238000002646 transcutaneous electrical nerve stimulation Methods 0.000 description 22
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 19
- 239000004744 fabric Substances 0.000 description 16
- 210000002683 foot Anatomy 0.000 description 16
- 238000012544 monitoring process Methods 0.000 description 16
- 210000001508 eye Anatomy 0.000 description 15
- 210000002414 leg Anatomy 0.000 description 15
- 230000015654 memory Effects 0.000 description 15
- 238000004088 simulation Methods 0.000 description 15
- 238000003860 storage Methods 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 14
- 230000037007 arousal Effects 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 13
- 206010062519 Poor quality sleep Diseases 0.000 description 13
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 13
- 230000001276 controlling effect Effects 0.000 description 13
- 206010022437 insomnia Diseases 0.000 description 13
- 230000003068 static effect Effects 0.000 description 13
- 206010041349 Somnolence Diseases 0.000 description 12
- 238000001816 cooling Methods 0.000 description 12
- 210000003128 head Anatomy 0.000 description 12
- 230000004461 rapid eye movement Effects 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 10
- 208000032140 Sleepiness Diseases 0.000 description 10
- 229910052802 copper Inorganic materials 0.000 description 10
- 239000010949 copper Substances 0.000 description 10
- 239000006260 foam Substances 0.000 description 10
- 230000036651 mood Effects 0.000 description 10
- 235000016709 nutrition Nutrition 0.000 description 10
- 239000005022 packaging material Substances 0.000 description 10
- 230000037081 physical activity Effects 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 230000004044 response Effects 0.000 description 10
- 208000019116 sleep disease Diseases 0.000 description 10
- 238000003466 welding Methods 0.000 description 10
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 230000004622 sleep time Effects 0.000 description 9
- 230000037321 sleepiness Effects 0.000 description 9
- 241001669679 Eleotris Species 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000035876 healing Effects 0.000 description 8
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- -1 polypropylene Polymers 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 230000007704 transition Effects 0.000 description 8
- 210000000476 body water Anatomy 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000007726 management method Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 230000036387 respiratory rate Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 230000006399 behavior Effects 0.000 description 6
- 230000002051 biphasic effect Effects 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 6
- 208000019901 Anxiety disease Diseases 0.000 description 5
- 238000004422 calculation algorithm Methods 0.000 description 5
- 230000002060 circadian Effects 0.000 description 5
- 239000000356 contaminant Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 229920001971 elastomer Polymers 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 208000019622 heart disease Diseases 0.000 description 5
- 230000017525 heat dissipation Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 230000001771 impaired effect Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000000977 initiatory effect Effects 0.000 description 5
- 201000006417 multiple sclerosis Diseases 0.000 description 5
- 230000008452 non REM sleep Effects 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 230000000241 respiratory effect Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- BXNJHAXVSOCGBA-UHFFFAOYSA-N Harmine Chemical compound N1=CC=C2C3=CC=C(OC)C=C3NC2=C1C BXNJHAXVSOCGBA-UHFFFAOYSA-N 0.000 description 4
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 4
- 206010067493 Sleep inertia Diseases 0.000 description 4
- 208000022249 Sleep-Wake Transition disease Diseases 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 4
- 238000004887 air purification Methods 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- 210000001217 buttock Anatomy 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 239000003574 free electron Substances 0.000 description 4
- 230000005802 health problem Effects 0.000 description 4
- 229960000890 hydrocortisone Drugs 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229960003987 melatonin Drugs 0.000 description 4
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 208000028173 post-traumatic stress disease Diseases 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000002040 relaxant effect Effects 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 230000004617 sleep duration Effects 0.000 description 4
- 230000000391 smoking effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000002618 waking effect Effects 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 208000002720 Malnutrition Diseases 0.000 description 3
- 206010028391 Musculoskeletal Pain Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 208000007613 Shoulder Pain Diseases 0.000 description 3
- 206010041235 Snoring Diseases 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 150000003943 catecholamines Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001149 cognitive effect Effects 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000001847 jaw Anatomy 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000010295 mobile communication Methods 0.000 description 3
- 208000015380 nutritional deficiency disease Diseases 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000002820 sympathetic nervous system Anatomy 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 210000005010 torso Anatomy 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920001771 Celliant Polymers 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 208000005793 Restless legs syndrome Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 210000001943 adrenal medulla Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 238000000222 aromatherapy Methods 0.000 description 2
- 210000003403 autonomic nervous system Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000746 body region Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000027288 circadian rhythm Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 208000024765 knee pain Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000005389 magnetism Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000002395 mineralocorticoid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008450 motivation Effects 0.000 description 2
- 230000036403 neuro physiology Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229940037129 plain mineralocorticoids for systemic use Drugs 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000001012 protector Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 208000022925 sleep disturbance Diseases 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000003270 steroid hormone Substances 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- 238000012384 transportation and delivery Methods 0.000 description 2
- 239000012855 volatile organic compound Substances 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000125 Abnormal dreams Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 108010074051 C-Reactive Protein Proteins 0.000 description 1
- 102100032752 C-reactive protein Human genes 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 240000007436 Cananga odorata Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000011688 Generalised anxiety disease Diseases 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020400 Hostility Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N L-glucitol Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000533950 Leucojum Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- 206010071368 Psychological trauma Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 244000284012 Vetiveria zizanioides Species 0.000 description 1
- 235000007769 Vetiveria zizanioides Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- 239000003462 bioceramic Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000006998 cognitive state Effects 0.000 description 1
- 230000036992 cognitive tasks Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000009429 electrical wiring Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000002567 electromyography Methods 0.000 description 1
- 239000012717 electrostatic precipitator Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 208000029364 generalized anxiety disease Diseases 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000012625 in-situ measurement Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004373 mandible Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical group [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 201000003631 narcolepsy Diseases 0.000 description 1
- 229910001172 neodymium magnet Inorganic materials 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 230000037053 non-rapid eye movement Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000011941 photocatalyst Substances 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 238000013439 planning Methods 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000001107 psychogenic effect Effects 0.000 description 1
- 230000008430 psychophysiology Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000012672 seasonal affective disease Diseases 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000005053 stress perception Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 230000003936 working memory Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
- F25D15/00—Devices not covered by group F25D11/00 or F25D13/00, e.g. non-self-contained movable devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B21/00—Machines, plants or systems, using electric or magnetic effects
- F25B21/02—Machines, plants or systems, using electric or magnetic effects using Peltier effect; using Nernst-Ettinghausen effect
-
- G—PHYSICS
- G04—HOROLOGY
- G04G—ELECTRONIC TIME-PIECES
- G04G13/00—Producing acoustic time signals
- G04G13/02—Producing acoustic time signals at preselected times, e.g. alarm clocks
-
- G—PHYSICS
- G04—HOROLOGY
- G04G—ELECTRONIC TIME-PIECES
- G04G21/00—Input or output devices integrated in time-pieces
- G04G21/02—Detectors of external physical values, e.g. temperature
-
- G—PHYSICS
- G04—HOROLOGY
- G04G—ELECTRONIC TIME-PIECES
- G04G21/00—Input or output devices integrated in time-pieces
- G04G21/02—Detectors of external physical values, e.g. temperature
- G04G21/025—Detectors of external physical values, e.g. temperature for measuring physiological data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4806—Sleep evaluation
- A61B5/4812—Detecting sleep stages or cycles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0016—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0022—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the tactile sense, e.g. vibrations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
- A61M2021/0033—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense subsonic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0055—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with electric or electro-magnetic fields
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0066—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0072—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with application of electrical currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0083—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus especially for waking up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
- A61M2205/052—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/054—General characteristics of the apparatus combined with other kinds of therapy with electrotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
- A61M2205/057—General characteristics of the apparatus combined with other kinds of therapy with magnetotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/332—Force measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3358—Measuring barometric pressure, e.g. for compensation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3375—Acoustical, e.g. ultrasonic, measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3379—Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M2205/3386—Low level detectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3561—Range local, e.g. within room or hospital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3569—Range sublocal, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/70—General characteristics of the apparatus with testing or calibration facilities
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/08—Supports for equipment
- A61M2209/088—Supports for equipment on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
- A61M2230/06—Heartbeat rate only
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
- A61M2230/10—Electroencephalographic signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
- A61M2230/14—Electro-oculogram [EOG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/30—Blood pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/42—Rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/50—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/60—Muscle strain, i.e. measured on the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/63—Motion, e.g. physical activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/65—Impedance, e.g. conductivity, capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25B—REFRIGERATION MACHINES, PLANTS OR SYSTEMS; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS
- F25B2321/00—Details of machines, plants or systems, using electric or magnetic effects
- F25B2321/02—Details of machines, plants or systems, using electric or magnetic effects using Peltier effects; using Nernst-Ettinghausen effects
- F25B2321/025—Removal of heat
- F25B2321/0252—Removal of heat by liquids or two-phase fluids
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F25—REFRIGERATION OR COOLING; COMBINED HEATING AND REFRIGERATION SYSTEMS; HEAT PUMP SYSTEMS; MANUFACTURE OR STORAGE OF ICE; LIQUEFACTION SOLIDIFICATION OF GASES
- F25D—REFRIGERATORS; COLD ROOMS; ICE-BOXES; COOLING OR FREEZING APPARATUS NOT OTHERWISE PROVIDED FOR
- F25D17/00—Arrangements for circulating cooling fluids; Arrangements for circulating gas, e.g. air, within refrigerated spaces
- F25D17/02—Arrangements for circulating cooling fluids; Arrangements for circulating gas, e.g. air, within refrigerated spaces for circulating liquids, e.g. brine
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Psychiatry (AREA)
- General Physics & Mathematics (AREA)
- Psychology (AREA)
- Pathology (AREA)
- Social Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Mechanical Engineering (AREA)
- Thermal Sciences (AREA)
- Anesthesiology (AREA)
- General Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Chemical & Material Sciences (AREA)
- Acoustics & Sound (AREA)
- Hematology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pain & Pain Management (AREA)
- Educational Technology (AREA)
- Combustion & Propulsion (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Air Conditioning Control Device (AREA)
Abstract
Description
本出願は、以下の米国特許及び特許出願に関するものであり、及び優先権を主張する:
2013年3月15日に出願された米国仮出願第61/800,768号の利益を主張する、2014年3月17日に出願された国内段階の国際出願第PCT/US2014/030202号である、2015年9月15日に出願された米国出願第14/777,050号の一部継続出願である、2017年9月15日に出願された米国出願第15/705,829号の一部継続出願である、2017年12月20日に出願された米国出願第15/848,816号。米国特許出願第15/705,829号は又、2016年9月22日に出願された米国仮出願第62/398,257号の利益も主張する。上記出願の各々は、その全体が参照により本明細書に組み込まれる。
本発明は一般に、ストレス低減及び睡眠促進のための部材、方法、及びシステムに関する。
、に記載される(各々その全体が参照により本明細書に組み込まれる)。スタンフォード眠気スケールは、Hoddes E. (1972). "The development and use of the stanford sleepiness scale (SSS)". Psychophysiology. 9 (150) 及び Maclean, ら (1992-03-01). "Psychometric evaluation of the Stanford Sleepiness Scale". Journal of Sleep Research. 1 (1): 35-39,に記載される(各々その全体が参照により本明細書に組み込まれる)。
好ましい実施形態では、ストレス低減及び睡眠促進システム700は、寝具の表面の温度を変化させるためにマットレス・パッド11を含む。図3は、本発明による熱電コントロール・ユニット10を示す。図示されるように、一対の同一のコントロール・ユニット10、10'は、可撓性がある導管を通してマットレス・パッド11等の温度調整部材に取り付けられている。マットレス・パッド11は、2つの独立した熱調節がなされる表面ゾーン「A」及び「B」(それぞれは、コントロール・ユニット10とマットレス・パッド11との間の液圧回路内で加温又は冷却された流体を循環させるように設計された可撓性(例えばシリコン)チューブ14を内部に含む)を有する。図3及び図4に最もよく示されているように、各コントロール・ユニット10のための可撓性導管アセンブリは、チューブ14に接続した別個の流体供給及び返送ライン16、17、並びにコントロール・ユニット10の外部オス・コネクタ19への着脱を簡単にするクイック−リリース・メス・コネクタ18、を含む。マットレス・パッド11によって、ユーザは既存のマットレスに組み込むことが可能となり、都合が良い。
好ましい実施形態では、ストレス低減及び睡眠促進システムは、パルス電磁場(PEMF)デバイスを含む。PEMF療法には、骨折の治癒、睡眠の改善、片頭痛やうつ病の治療など、多くの適用がある。前記PEMFデバイスは、少なくとも1つの誘導コイルに送られるAC又はDC出力を生成する回路と組み合わさった電源を含む。前記誘導コイルは、中空又は鉄のコアを有するコイル本体に巻き付けられたワイヤ巻線で形成される。前記誘導コイルは、前記回路からの出力に応じて電磁場(EMF)を発散する。好ましい実施形態では、前記誘導コイルは、銅から形成される。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムには、経皮電気的神経刺激(TENS)デバイスが含まれる。TENSは、疼痛緩和のために電気刺激を用いる治療法の一形態である。TENSデバイスの例としては、米国特許第8,948,876号、9,675,801号、及び9,731,126号並びに米国特許出願公開第20140296935号、20140309709号、及び20170056643号が挙げられる(これらの各々は、その全体が参照により本明細書に組み込まれる)。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムには、音発生器が含まれる。音は睡眠にポジティブな影響を与え、痛みを緩和し、ストレスを管理し、健康を促進することができる。音は人を入眠させたり、睡眠ステージ間を移行させたり、目覚めさせたりすることがある。音(ホワイトノイズ、心拍、又は環境音(例えば、雨、海の波、雷雨、雨林、風、鳥、河川、滝、都市騒音)等を含むが、これらに限定されない)は、ユーザが入眠し、睡眠を続けることを補助することができる。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムには、空気清浄システムが含まれる。前記空気清浄システムは、睡眠環境から大気汚染物質及びアレルゲンを除去する。前記空気清浄システムは、高効率微粒子捕捉(HEPA)フィルター、活性炭フィルター、光触媒(例えば、二酸化チタン)フィルター、偏光媒体電子空気清浄機(polarized-media electronic air cleaner)、陰イオン発生器又はイオン化装置、殺菌UVランプ、加熱滅菌器、サイズ除去フィルター、及び/又は静電集塵機である。ある実施形態では、前記空気清浄システムは、サード・パーティのシステム及び/又はホーム・オートメーション・システム(例えば、Amazon登録商標 Alexa登録商標、Apple登録商標 HomeKit登録商標、Google登録商標 Home登録商標、IF This Then That登録商標(IFTTT登録商標)、Nest登録商標)を介して設定(例えば、オン/オフ)を変更するように動作可能である。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムには、リラクゼーション並びに睡眠及び/又は覚醒状態をトリガするための香り発生器が含まれる。ある香り(例えば、ラベンダー、ベチバー、カモミール、イランイランノキ、ベルガモット、サンダルウッド、マルジョラム、スギウッド、ジャスミン、バニラ、ゲラニウム、バラ)は、リラクゼーション及び睡眠を引き起こす。他の香り(例えば、コーヒー、レモン、シナモン、ミント、オレンジ、グレープフルーツ、ローズマリー)は覚醒状態を引き起こす。
前記ストレス低減及び睡眠促進システムは、室内及び/又は家屋内の照明をコントロールするように動作可能である。ある実施形態では、前記照明には、少なくとも1つのスマート照明電球(例えば、Philips登録商標 Hue登録商標、Cree登録商標 Connected登録商標、GE登録商標によるC)が含まれる。好ましい実施形態では、前記ストレス低減及び睡眠促進システムは、前記照明の色彩及び/又は強さを変化させるように動作可能である。ある実施例では、前記ストレス低減及び睡眠促進システムは、朝に青色光を含み、人を目覚めさせ、夜間に青色光を減少させて睡眠を促進する。別の実施例では、前記ストレス低減及び睡眠促進システムは、夜間の照明を暗くし、午前中の照明の強さを増加させる。ある実施形態では、前記ストレス低減及び睡眠促進システムは、外部アプリケーション及び/又はホーム・オートメーション・システム(例えば、Amazon登録商標 Alexa登録商標、Apple登録商標 HomeKit登録商標、Google登録商標 Home登録商標、IF This Then That登録商標(IFTTT登録商標)、Nest登録商標)と統合して、前記照明をコントロールする。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムは、室温、ファン、加湿器、及び/又は除湿器の設定(例えば、オン/オフ、温度上昇、温度低下)をコントロールするように動作可能である。ある実施形態では、前記ストレス低減及び睡眠促進システムは、サード・パーティのシステム及び/又はホーム・オートメーション・システム(例えば、Amazon登録商標 Alexa登録商標、Apple登録商標 HomeKit登録商標、Google登録商標 Home登録商標、IF This Then That登録商標(IFTTT登録商標)、Nest登録商標)を介して前記設定を変更するように動作可能である。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムには、目覚まし時計が含まれる。ある実施形態では、前記目覚まし時計は、前記リモート・デバイスに組み込まれている。別の実施形態では、前記目覚まし時計は、日の出シミュレーター及び/又は日没シミュレーターを含む。
ある実施形態では、前記ストレス低減及び睡眠促進システムには、目標の電磁場(EMF)に較正シグナルを発するデバイスが含まれる。EMFは、電力の使用及び種々の形態の照明(例えば、自然、人工)に関連した放射である。これらのEMFは、前記身体にストレスを引き起こすことがあり、これはエネルギー及び免疫応答の低下を引き起こす。更に、EMFは、体内でのメラトニンの産生を減少させることがある。EMFに暴露されることに関する症状には、頭痛、疲労、易刺激性、抑うつ、不眠、記憶の低下、及び/又は息切れなどが含まれることがある。
ある実施形態では、前記ストレス低減及び睡眠促進システムには、静磁場を発生させるためのデバイスが含まれる。静磁気は、ブレスレット、靴インサート、ネックレス、及び寝具にしばしば使用され、磁石及びその静磁場と接触するようになる組織に対して、微妙な影響を与える。静磁場は、使用又は測定の時間隔にわたって、磁束密度又は強度に変化を示さない。静磁場は、痛みを改善し、睡眠障害から救済することがある。好ましい実施形態では、前記静磁場を使用して、鍼療法の経線に沿ってユーザの身体を刺激する。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムには、ユーザの身体を接地又はアースするためのデバイスが含まれる。接地又はアースとは、屋外を裸足で歩くことによって、又は室内の場合は接地された導電マット、ベッドシーツ、又はボディ・バンドを使用して、個人が静電的に地球と接触する行為である。接地は、地球が負に帯電した自由電子の供給源であるという理論に基づいており、地球と接触すると、前記身体は、体内のフリーラジカルを中和するために、これらの自由電子を酸化防止剤として使用することができる。睡眠の改善、疼痛の減少、コルチゾールに対する効果の正常化、ストレスの低減及び/又は正常化、遅発性筋肉痛に起因する筋肉への損傷の減少、骨粗鬆症の主要な指標の低減、グルコース調節の改善、及び免疫機能の増強、等を含む広範囲にわたる健康関連の結果を、過去10年間にわたって発表された研究は、報告している。ある実施形態では、前記身体に接する表面(例えば、マットレス・パッド、シート)には、コンセントの接地ポートへ電気的に接続するワイヤが取り付けられている。或いは、前記身体と接触する表面には、接地ロッドに接続するワイヤが取り付けられている。前記身体を接地するためのデバイスの例は、米国特許第6,683,779、7212,392、及び7724,491号(これらの各々は、その全体が参照により本明細書に組み込まれる) に記載されている。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムは、遠赤外線反射技術(例えば、Celliant(登録商標)、Redwave(登録商標))を含む。前記遠赤外線反射技術は、体内の熱を吸収して、体内の筋肉や組織への血流を増加させる赤外線(IR)エネルギーに変換する。前記遠赤外線反射技術は、ポリエチレン・テレフタレートの繊維(例えば、Celliant(登録商標))から形成されるか、又はバイオセラミック(例えば、Redwave(登録商標))を組み込む。ある実施形態では、前記遠赤外線反射技術には、一セットのシーツ、ベッドカバー(例えば、羽毛布団(comforter)、羽毛布団(duvet)、羽毛布団(duvet)カバー)、又はマットレス・カバーが含まれる。別の実施形態では、前記遠赤外線反射技術は、睡眠ウェアに含まれる。
好ましい実施形態では、前記ストレス低減及び睡眠促進システムには、電磁場遮蔽が含まれる。電磁場(EMF)は、ワイヤレス技術(例えば、Wi-Fi)、電力線、携帯電話や携帯電話の塔、コードレス電話、家庭や企業の電気配線、電化製品(例えば、テレビ、電子レンジ)、コンピュータ、ラジオ、スマート・メータ、照明により、現代の日常生活の中に存在している。ある研究者は、EMFに対する遮蔽(特に睡眠中の遮蔽、なぜなら、この時期は、身体がそれ自身を修復するときであるからである。)を提唱している。電磁場は、メラトニン(メラトニンは、日々の睡眠/覚醒サイクルの調節を担っている)の産生を破壊することがある。これは、免疫系の抑制等を含む長期的な健康への影響につながる可能性がある。
図27は、統合ベッド・システム2700のある実施形態を示す。統合ベッド・システム2700は、ヘッドボード2702と、フットボード2704と、マットレス102及び箱スプリング又はファンデーション104を支持するベッド・フレーム2706とを含む。ある実施形態では、ヘッドボード2702、フットボード2704、及び/又はベッド・フレーム2706は、EMF遮蔽及び/又は陽イオン遮蔽を含む。
Claims (20)
- 以下を含むストレス低減及び睡眠促進システム:
少なくとも1つのリモート・デバイス;並びに、
表面の温度を調節するための部材、ここで、前記部材は、更に以下を含む:
第1層、ここで、前記第1層は、外面及び内面を有する;
第2層、ここで、前記第2層は、外面及び内面を有する、並びにここで、前記第2層は、前記部材の周縁に沿って前記第1層に永久的に貼り付けられている;
第1層の内面と第2層の内面との間に画定される少なくとも1つの内部チャンバー;
少なくとも1つの内部チャンバーに流体を送達するための少なくとも1つの可撓性流体供給ライン;
少なくとも1つの内部チャンバーから流体を除去するための少なくとも1つの可撓性流体返送ライン;並びに、
前記少なくとも1つの可撓性流体供給ライン及び前記少なくとも1つの可撓性流体返送ラインに取り付けられた少なくとも1つのコントロール・ユニット、ここで、前記少なくとも1つのコントロール・ユニットは、前記流体を選択的に冷却又は加温するように動作可能である、並びにここで、前記少なくとも1つのコントロール・ユニットは、少なくとも1つのアンテナ及び少なくとも1つのプロセッサを有する;
ここで、前記少なくとも1つのリモート・デバイス及び前記少なくとも1つのコントロール・ユニットは、リアル-タイム又は近-リアル-タイムの双方向通信をする;
ここで、前記少なくとも1つの内部チャンバーは、漏らすことなく前記流体を保持するように構築及び構成される;
ここで、第1層の内面及び第2層の内面は、防水の材料でできた少なくとも1つの層から構成される;
ここで、前記第1層は、複数の孔を有する;
ここで、前記第2層は、対応する複数の孔を有する;並びに、
ここで、前記第2層は、前記複数の孔のそれぞれの周縁に沿って前記第1層に永久的に貼り付けられている。 - 前記少なくとも1つのリモート・デバイスとリアル-タイム又は近-リアル-タイムで双方向通信をする、少なくとも1つのリモート・サーバを更に含む、請求項1に記載のストレス低減及び睡眠促進システム。
- 少なくとも1つの身体センサを更に含む、ここで、前記少なくとも1つの身体センサは、呼吸センサ、電子眼球運動センサ、心拍数センサ、体重センサ、動作センサ、筋電図センサ、脳波センサ、体温センサ、アナライト・センサ、パルス・オキシメータ・センサ、血圧センサ、皮膚電位センサ、及び/又は体脂肪センサである、請求項1に記載のストレス低減及び睡眠促進システム。
- 少なくとも1つの環境センサを更に含む、ここで、前記環境センサは、温度センサ、湿度センサ、ノイズ・センサ、大気質センサ、光センサ、運動センサ及び/又は気圧センサである、請求項1に記載のストレス低減及び睡眠促進システム。
- 前記少なくとも1つのコントロール・ユニットは、前記少なくとも1つのリモート・デバイスからパラメータを受信して、前記表面の前記温度を修正するように動作可能である、請求項1に記載のストレス低減及び睡眠促進システム。
- 前記少なくとも1つのリモート・デバイスは、BLUETOOTH、RADIOFREQUENCY、ZIGBEE、WI-FI、又はNEAR FIELD COMMUNICATIONを介して前記パラメータをワイヤレスに送信する、請求項5に記載のストレス低減及び睡眠促進システム。
- 前記表面の温度が、前記ストレス低減及び睡眠促進システムについての予測値、少なくとも1つの身体センサからのデータ、及び/又は少なくとも1つの環境センサからのデータを含む仮想モデルに基づいて最適化される、請求項1に記載のストレス低減及び睡眠促進システム。
- 調節可能な硬さ及び/又は高さを有するマットレス、目覚まし時計、加湿器、除湿器、パルス電磁場デバイス、経皮電気的神経刺激デバイス、音発生器、空気清浄機、香り発生器、赤色及び/若しくは近赤外照明、日の出シミュレーター、並びに/又は日没シミュレーターを更に含む、請求項1に記載のストレス低減及び睡眠促進システム。
- ホーム・オートメーション・システムを更に含む、ここで、前記少なくとも1つのリモート・デバイスは、前記ホーム・オートメーション・システムに命令を送信して環境条件を調整するように、動作可能である、請求項1に記載のストレス低減及び睡眠促進システム。
- 前記流体が水である、請求項1に記載のストレス低減及び睡眠促進システム。
- 以下を含むストレス低減及び睡眠促進システム:
少なくとも1つの身体センサ;
少なくとも1つのリモート・デバイス;
少なくとも1つのリモート・サーバ;並びに、
表面の温度を調節するための部材、ここで前記部材は、更に以下を含む:
第1層、ここで、前記第1層は、外面及び内面を有する;
第2層、ここで、前記第2層は、外面及び内面を有する、並びにここで、前記第2層は、前記部材の周縁に沿って前記第1層に永久的に貼り付けられている;
第1層の内面と第2層の内面との間に画定される少なくとも1つの内部チャンバー;
少なくとも1つの内部チャンバーに流体を送達するための少なくとも1つの可撓性流体供給ライン;
少なくとも1つの内部チャンバーから流体を除去するための少なくとも1つの可撓性流体返送ライン;並びに、
前記少なくとも1つの可撓性流体供給ライン及び前記少なくとも1つの可撓性流体返送ラインに取り付けられた少なくとも1つのコントロール・ユニット、ここで、前記少なくとも1つのコントロール・ユニットは、前記流体を選択的に冷却又は加温するように動作可能である、並びにここで、前記少なくとも1つのコントロール・ユニットは、少なくとも1つのアンテナ及び少なくとも1つのプロセッサを有する;
ここで、前記少なくとも1つのリモート・サーバ及び前記少なくとも1つのリモート・デバイスは、リアル-タイム又は近-リアル-タイムの双方向通信をする;
ここで、前記少なくとも1つのリモート・デバイス及び前記少なくとも1つのコントロール・ユニットは、リアル-タイム又は近-リアル-タイムの双方向通信をする;
ここで、前記少なくとも1つのリモート・サーバは、前記少なくとも1つの身体センサからのデータに基づいて、前記部材のための最適化したパラメータを自律的に決定するように動作可能である、ここで、前記少なくとも1つの身体センサからの前記データに基づいてユーザの睡眠ステージが決定される;
ここで、前記少なくとも1つのリモート・サーバは、前記部材のための前記最適化したパラメータを前記少なくとも1つのリモート・デバイスに送信するように動作可能である;
ここで、前記少なくとも1つのリモート・デバイスは、前記部材のための前記最適化したパラメータを前記少なくとも1つのコントロール・ユニットに送信するように動作可能である;
ここで、前記少なくとも1つの内部チャンバーは、漏らすことなく前記流体を保持するように構築及び構成される;並びに、
ここで、第1層の内面及び第2層の内面は、防水の材料でできた少なくとも1つの層から構成される。 - 前記少なくとも1つの身体センサは、呼吸センサ、電子眼球運動センサ、心拍数センサ、体重センサ、動作センサ、筋電図センサ、脳波センサ、体温センサ、アナライト・センサ、パルス・オキシメータ・センサ、血圧センサ、皮膚電位センサ、及び/又は体脂肪センサである、請求項11に記載のストレス低減及び睡眠促進システム。
- 前記少なくとも1つのコントロール・ユニットは、前記少なくとも1つのリモート・デバイスからパラメータを受信して前記表面の前記温度を修正するように動作可能である、請求項11に記載のストレス低減及び睡眠促進システム。
- 前記少なくとも1つのリモート・デバイスは、BLUETOOTH、RADIOFREQUENCY、ZIGBEE、WI-FI、又はNEAR FIELD COMMUNICATIONを介して前記パラメータをワイヤレスに送信する、請求項11に記載のストレス低減及び睡眠促進システム。
- 前記第1層は、複数の孔を有する;
前記第2層は、対応する複数の孔を有する;及び、
前記第2層は、前記複数の孔のそれぞれの周縁に沿って前記第1層に永久的に貼り付けられている、
請求項11に記載のストレス低減及び睡眠促進システム。 - 調節可能な硬さ及び/又は高さを有するマットレス、目覚まし時計、加湿器、除湿器、パルス電磁場デバイス、経皮電気的神経刺激デバイス、音発生器、空気清浄機、香り発生器、赤色及び/若しくは近赤外照明、日の出シミュレーター、並びに/又は日没シミュレーターを更に含む、請求項11に記載のストレス低減及び睡眠促進システム。
- 少なくとも1つの環境センサを更に含む、ここで、前記環境センサは、温度センサ、湿度センサ、ノイズ・センサ、大気質センサ、光センサ、運動センサ及び/又は気圧センサである、請求項11に記載のストレス低減及び睡眠促進システム。
- ホーム・オートメーション・システムを更に含む、ここで、前記少なくとも1つのリモート・デバイスは、前記ホーム・オートメーション・システムに命令を送信して環境条件を調整するように、動作可能である、請求項11に記載のストレス低減及び睡眠促進システム。
- 前記少なくとも1つの身体センサ及び前記少なくとも1つのリモート・デバイスは、リアル-タイム又は近-リアル-タイムの双方向通信をする、請求項11に記載のストレス低減及び睡眠促進システム。
- 以下を含むストレス低減及び睡眠促進システム:
少なくとも1つの身体センサ;
少なくとも1つのリモート・デバイス;
少なくとも1つのリモート・サーバ;
パルス電磁周波数デバイス、ここで、前記パルス電磁周波数デバイスは、更に以下を含む:
少なくとも1つの誘導コイル;
前記少なくとも1つの誘導コイルに伝送される交流(AC)又は直流(DC)出力を生成する回路と組み合わさった電源;
少なくとも1つのアンテナ;及び、
少なくとも1つのプロセッサ;並びに、
表面の温度を調整するための部材、ここで、前記部材は、更に以下を含む:
第1層、ここで、前記第1層は、外面及び内面を有する;
第2層、ここで、前記第2層は、外面及び内面を有する、並びにここで、前記第2層は、前記部材の周縁に沿って前記第1層に永久的に貼り付けられている;
第1層の内面と第2層の内面との間に画定される少なくとも1つの内部チャンバー;
少なくとも1つの内部チャンバーに流体を送達するための少なくとも1つの可撓性流体供給ライン;
少なくとも1つの内部チャンバーから流体を除去するための少なくとも1つの可撓性流体返送ライン;並びに、
前記少なくとも1つの可撓性流体供給ライン及び前記少なくとも1つの可撓性流体返送ラインに取り付けられた少なくとも1つのコントロール・ユニット、ここで、前記少なくとも1つのコントロール・ユニットは、前記流体を選択的に冷却又は加温するように動作可能である、並びにここで、前記少なくとも1つのコントロール・ユニットは、少なくとも1つのアンテナ及び少なくとも1つのプロセッサを有する;
ここで、前記少なくとも1つの身体センサ及び前記少なくとも1つのリモート・デバイスは、リアル-タイム又は近-リアル-タイムの双方向通信をする;
ここで、前記少なくとも1つのリモート・サーバ及び前記少なくとも1つのリモート・デバイスは、リアル-タイム又は近-リアル-タイムの双方向通信をする;
ここで、前記少なくとも1つのリモート・デバイス及び前記少なくとも1つのコントロール・ユニットは、リアル-タイム又は近-リアル-タイムの双方向通信をする;
ここで、前記少なくとも1つのリモート・デバイス及び前記パルス電磁周波数デバイスは、リアル-タイム又は近-リアル-タイムの双方向通信をする;
ここで、前記少なくとも1つのリモート・サーバは、前記少なくとも1つの身体センサからのデータに基づいて、前記部材及び/又は前記パルス電磁周波数デバイスのための最適化したパラメータを自律的に決定するように動作可能である;
ここで、前記少なくとも1つのリモート・サーバは、前記部材及び/又は前記パルス電磁周波数デバイスのための前記最適化したパラメータを前記少なくとも1つのリモート・デバイスに送信するように動作可能である;
ここで、前記少なくとも1つのリモート・デバイスは、前記部材のための前記最適化したパラメータを前記少なくとも1つのコントロール・ユニットに送信するように動作可能である;
ここで、前記少なくとも1つのリモート・デバイスは、前記部材のための前記最適化したパラメータを前記パルス電磁周波数デバイスに送信するように動作可能である;
ここで、前記少なくとも1つの内部チャンバーは、漏らすことなく前記流体を保持するように構築及び構成される;並びに、
ここで、第1層の内面及び第2層の内面は、防水の材料でできた少なくとも1つの層から構成される。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/705,829 US10986933B2 (en) | 2013-03-15 | 2017-09-15 | Article comprising a temperature-conditioned surface, thermoelectric control unit, and method for temperature-conditioning the surface of an article |
US15/705,829 | 2017-09-15 | ||
US15/848,816 US11013883B2 (en) | 2013-03-15 | 2017-12-20 | Stress reduction and sleep promotion system |
US15/848,816 | 2017-12-20 | ||
PCT/US2018/050463 WO2019055414A2 (en) | 2017-09-15 | 2018-09-11 | STRESS REDUCTION AND SLEEP PROMOTION SYSTEM |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020534118A true JP2020534118A (ja) | 2020-11-26 |
Family
ID=65723041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020536912A Pending JP2020534118A (ja) | 2017-09-15 | 2018-09-11 | ストレス低減及び睡眠促進システム |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3681576A4 (ja) |
JP (1) | JP2020534118A (ja) |
CN (1) | CN111344033A (ja) |
AU (1) | AU2018332812B2 (ja) |
WO (1) | WO2019055414A2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11793426B2 (en) | 2019-08-27 | 2023-10-24 | Turtle Shell Technologies Private Limited | System and a method for determining breathing rate as a biofeedback |
EP3826281A1 (en) * | 2019-11-20 | 2021-05-26 | Koninklijke Philips N.V. | A system and method for waking a user up with a stimulus of varying intensity |
JP2023533396A (ja) * | 2020-07-10 | 2023-08-02 | メタフィジクス エンジニアリング ソシエテ アノニム | 被験体の入眠を促進するおよび/または睡眠の質を改善するための方法 |
CN111991672B (zh) * | 2020-09-03 | 2022-05-31 | 哈工天愈(中山)机器人有限公司 | 一种智能助眠机器人 |
WO2024042393A1 (en) * | 2023-07-20 | 2024-02-29 | Gholizadeh Soltani Jalil | Electromagnetic point stimulation of the synaptic space for the treatment of various neurological disorders |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001506877A (ja) * | 1996-11-25 | 2001-05-29 | キネティック・コンセプツ・インコーポレイテッド | 患者支持体と利用する温度制御 |
US20050143617A1 (en) * | 2003-12-31 | 2005-06-30 | Raphael Auphan | Sleep and environment control method and system |
KR20110102637A (ko) * | 2010-03-11 | 2011-09-19 | 이상홍 | 펄스화 전자기장 온열매트 |
US20160136385A1 (en) * | 2014-11-14 | 2016-05-19 | Ruggero Scorcioni | System and method for thermally conditioning a sleep environment and managing skin temperature of a user |
WO2016157641A1 (ja) * | 2015-03-27 | 2016-10-06 | ソニー株式会社 | 情報処理装置、情報処理方法、およびプログラム |
US20160361515A1 (en) * | 2015-06-11 | 2016-12-15 | Samsung Electronics Co., Ltd. | Method and apparatus for controlling temperature adjustment device |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6551347B1 (en) * | 1988-09-28 | 2003-04-22 | Life Enhancement Technologies, Inc. | Cooling/heating system |
US5033136A (en) * | 1988-09-28 | 1991-07-23 | Life Support Systems, Inc. | Bedding system with selective heating and cooling |
US4884304A (en) * | 1988-09-28 | 1989-12-05 | Life Support Systems, Inc. | Bedding system with selective heating and cooling |
US5448788A (en) * | 1994-03-08 | 1995-09-12 | Wu; Shuenn-Jenq | Thermoelectric cooling-heating mattress |
CN1051196C (zh) * | 1994-06-04 | 2000-04-05 | 刘博文 | 磁疗电热毯 |
US6273810B1 (en) * | 1999-09-10 | 2001-08-14 | Mccord Winn Textron Inc. | Inflatable air cell having combined pneumatically adjusted occupant support and thermal conditioning |
EP1290652A2 (en) * | 2000-05-05 | 2003-03-12 | Hill-Rom Services, Inc. | Hospital monitoring and control system and method |
US20070251016A1 (en) * | 2004-12-28 | 2007-11-01 | Steve Feher | Convective seating and sleeping systems |
US20060137099A1 (en) * | 2004-12-28 | 2006-06-29 | Steve Feher | Convective cushion with positive coefficient of resistance heating mode |
US20160247065A1 (en) * | 2006-02-14 | 2016-08-25 | Power Analytics Corporation | Systems and Methods for Real-Time Forecasting and Predicting of Electrical Peaks and Managing the Energy, Health, Reliability, and Performance of Electrical Power Systems Based on an Artificial Adaptive Neural Network |
US20090000031A1 (en) * | 2007-06-29 | 2009-01-01 | Steve Feher | Multiple convective cushion seating and sleeping systems and methods |
CN104523071A (zh) * | 2008-07-18 | 2015-04-22 | 金瑟姆股份公司 | 气候受控床组件 |
CN101401695B (zh) * | 2008-10-16 | 2010-10-13 | 浙江惠鸿光电科技有限公司 | 制冷-加热毯 |
US8444558B2 (en) * | 2009-01-07 | 2013-05-21 | Bam Labs, Inc. | Apparatus for monitoring vital signs having fluid bladder beneath padding |
US8359871B2 (en) * | 2009-02-11 | 2013-01-29 | Marlow Industries, Inc. | Temperature control device |
US8332975B2 (en) * | 2009-08-31 | 2012-12-18 | Gentherm Incorporated | Climate-controlled topper member for medical beds |
US20110073292A1 (en) * | 2009-09-30 | 2011-03-31 | Madhav Datta | Fabrication of high surface area, high aspect ratio mini-channels and their application in liquid cooling systems |
US20130019611A1 (en) * | 2010-10-27 | 2013-01-24 | John Sims | Personal Temperature Control System |
US20130081479A1 (en) * | 2011-09-30 | 2013-04-04 | Craig Miller | Sensor system to detect persence of a person on an object and monitoring system comprising a sensor system to detect persence of a person |
JP6182153B2 (ja) * | 2011-11-21 | 2017-08-16 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | ヒトの睡眠を改善するシステム及び方法 |
US9402763B2 (en) * | 2012-09-12 | 2016-08-02 | Breg, Inc. | Cold therapy apparatus having heat exchanging therapy pad |
CN202788030U (zh) * | 2012-09-24 | 2013-03-13 | 积水住宅株式会社 | 居住用设施 |
US9955791B2 (en) * | 2012-12-28 | 2018-05-01 | Tempur-Pedic Management, Llc | Climate controlled mattress assembly and related method |
WO2014145436A1 (en) * | 2013-03-15 | 2014-09-18 | Youngblood Todd | Article comprising a temperature-conditioned surface, thermoelectric control unit, and method for temperature-conditioning the surface of an article |
US20140316495A1 (en) * | 2013-04-17 | 2014-10-23 | Augustine Biomedical And Design, Llc | Conformable heated mattress |
CN103780691B (zh) * | 2014-01-20 | 2017-10-10 | 魔玛智能科技(上海)有限公司 | 智慧睡眠系统及其用户端系统和云端系统 |
US10610153B2 (en) * | 2014-07-21 | 2020-04-07 | Withings | System and method to monitor and assist individual's sleep |
CN104188638B (zh) * | 2014-09-09 | 2016-08-24 | 喜临门家具股份有限公司 | 一种睡眠保障系统 |
-
2018
- 2018-09-11 EP EP18856293.8A patent/EP3681576A4/en not_active Withdrawn
- 2018-09-11 CN CN201880073899.6A patent/CN111344033A/zh active Pending
- 2018-09-11 AU AU2018332812A patent/AU2018332812B2/en active Active
- 2018-09-11 WO PCT/US2018/050463 patent/WO2019055414A2/en unknown
- 2018-09-11 JP JP2020536912A patent/JP2020534118A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001506877A (ja) * | 1996-11-25 | 2001-05-29 | キネティック・コンセプツ・インコーポレイテッド | 患者支持体と利用する温度制御 |
US20050143617A1 (en) * | 2003-12-31 | 2005-06-30 | Raphael Auphan | Sleep and environment control method and system |
KR20110102637A (ko) * | 2010-03-11 | 2011-09-19 | 이상홍 | 펄스화 전자기장 온열매트 |
US20160136385A1 (en) * | 2014-11-14 | 2016-05-19 | Ruggero Scorcioni | System and method for thermally conditioning a sleep environment and managing skin temperature of a user |
WO2016157641A1 (ja) * | 2015-03-27 | 2016-10-06 | ソニー株式会社 | 情報処理装置、情報処理方法、およびプログラム |
US20160361515A1 (en) * | 2015-06-11 | 2016-12-15 | Samsung Electronics Co., Ltd. | Method and apparatus for controlling temperature adjustment device |
Also Published As
Publication number | Publication date |
---|---|
EP3681576A2 (en) | 2020-07-22 |
WO2019055414A3 (en) | 2019-05-02 |
AU2018332812A1 (en) | 2020-03-26 |
CN111344033A (zh) | 2020-06-26 |
WO2019055414A2 (en) | 2019-03-21 |
WO2019055414A4 (en) | 2019-07-11 |
AU2018332812B2 (en) | 2024-03-21 |
EP3681576A4 (en) | 2021-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210268226A1 (en) | Stress reduction and sleep promotion system | |
US11812859B2 (en) | System for enhancing sleep recovery and promoting weight loss | |
US11744382B2 (en) | Article comprising a temperature-conditioned surface, thermoelectric control unit, and method for temperature-conditioning the surface of an article | |
AU2018332812B2 (en) | Stress reduction and sleep promotion system | |
US11813076B2 (en) | Stress reduction and sleep promotion system | |
US11633053B2 (en) | Weighted blanket with thermally regulated fluid | |
US20210386964A1 (en) | Smart platform for stress reduction and sleep promotion | |
US20210219737A1 (en) | Article and system for heating or cooling a surface | |
US11896132B2 (en) | System for heat exchange with a circulating fluid | |
US11602611B2 (en) | System for enhancing sleep recovery and promoting weight loss | |
CN108078565A (zh) | 一种睡眠监测反馈及睡眠自动改善装置 | |
US11883606B2 (en) | Stress reduction and sleep promotion system | |
US10537702B2 (en) | Lucid dream stimulator, systems, and related methods | |
US20220168539A1 (en) | Stress reduction and sleep promotion system | |
KR20120131253A (ko) | 라이트 테라피 및 사운드 테라피와 연계된 압전센서 기반의 숙면 침대 시스템 | |
CN109982610A (zh) | 包括温度调节表面的制品、热电控制单元和调节制品表面温度的方法 | |
Rubert et al. | Creating a healing environment in the ICU | |
US11896774B2 (en) | System for enhancing sleep recovery and promoting weight loss | |
US20240157085A1 (en) | Stress reduction and sleep promotion system | |
US20240149061A1 (en) | Systems and methods for treating pain and/or inflammation | |
Hema et al. | Audio Visual Entrainment and Acupressure Therapy for Insomnia | |
CA3040546A1 (en) | System for delivering ultra-low frequency (ulf), variable-intensity, non-vibratory tactile stimuli for regulating physiological processes, and modulating mental states | |
Melissa et al. | Creating a Healing Environment in the ICU |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210818 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220428 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220510 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220801 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221122 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230620 |